{"text": "but serious side effect. According to a study published in the Journal of\n\nClinical Psychopharmacology, approximately 0.1% of patients taking Abilify\n\nexperience NMS (3). NMS is a life-threatening condition that requires\n\nimmediate medical attention.\n\nTardive Dyskinesia\n\nAbilify may increase the risk of tardive dyskinesia, a rare but serious side\n\neffect. According to a study published in the Journal of Clinical\n\nPsychopharmacology, approximately 0.1% of patients taking Abilify experience", "embedding": []}